OxyContin maker Purdue Pharma pleads guilty in criminal case

purdue_pharma.jpg
FILE- In this Oct. 21, 2020, file photo Purdue Pharma headquarters stands in Stamford, Conn. Purdue Pharma pleaded guilty Tuesday, Nov. 24 to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades. (AP Photo/Mark Lennihan, File)

Purdue Pharma pleaded guilty Tuesday to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades.

In a virtual hearing with a federal judge in Newark, New Jersey, the OxyContin maker admitted impeding the U.S. Drug Enforcement Administration’s efforts to combat the addiction crisis. Purdue acknowledged that it had not maintained an effective program to prevent prescription drugs from being diverted to the black market, even though it had told the DEA it did have such a program, and that it provided misleading information to the agency as a way to boost company manufacturing quotas.

Close